Drugmakers
-
Health After Slow Start, States Are Flush With COVID-19 Antiviral Pills. But Federal Data Shows Some Are Slow to Give Them Out
June 23, 2022
-
Health 2 in 3 Democrats and 2 in 5 Republicans Back Proposal to Waive COVID-19 Vaccine Patent Rights
February 9, 2022
-
Health Incoming PhRMA Chair Expects Drugmakers to Face ‘Some Pain’ in 2022 Amid Reform and Efforts to Rebuild Patient Trust
January 25, 2022
-
Health Clinical Trials Are Slow and Expensive. Industry Leaders Want That to Change in 2022
December 21, 2021
-
Health The FDA Is Expected to Authorize COVID-19 Antiviral Pills. 3 in 4 Adults Say They’d Take Them if They Got Sick
November 29, 2021
-
Health As Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time
September 5, 2019